Product Images Sutent

View Photos of Packaging, Labels & Appearance

Product Label Images

The following 11 images provide visual information about the product associated with Sutent NDC 0069-0830 by Pfizer Laboratories Div Pfizer Inc, such as packaging, labeling, and the appearance of the drug itself. This resource could be helpful for medical professionals, pharmacists, and patients seeking to verify medication information and ensure they have the correct product.

Chemical Structure - sutent 01

Chemical Structure - sutent 01

Figure 1 - sutent 02

Figure 1 - sutent 02

This is a comparison of the median weeks of SUTENT versus placebo conducted on 207 and 105 individuals respectively. The results show a significant difference in efficacy, with SUTENT having a median of 27.3 weeks while the placebo only had 6.4 weeks. The Hazard R is 3 with a 95% confidence interval between 0.23 and 0.47, indicating a strong effect size.*

Figure 2 - sutent 03

Figure 2 - sutent 03

This text appears to be a table showing the Progression Free Survival Probability of two treatments SUTENT and FlNa. The median progression-free survival probability with SUTENT treatment is 47.3 weeks whereas with FlNa treatment it is 22.0 weeks. The table also includes some numerical values in the form of hazards ratio and probability, and the number of patients in each group.*

Figure 3 - sutent 04

Figure 3 - sutent 04

This appears to be a chart showing the results of a clinical trial comparing SUTENT (N-309) to placebo (N-306) over a period of up to 6.8 years. The chart shows the number of subjects at risk over time and includes a hazard ratio and confidence interval.*

Figure 4 - sutent 05

Figure 4 - sutent 05

This text provides information on the progression-free survival probability of SUTENT compared to a placebo. The data shows that SUTENT has a higher survival probability percentage than the placebo group, with a median of 10.2 months compared to 5 months. The graph also displays the time in months on the x-axis and the survival probability on the y-axis.*

Pfizer Logo - sutent 06

Pfizer Logo - sutent 06

This text is a distribution information for Pfizer Labs, which is a division of Pfizer Inc located in NY, NY 10017. It suggests that Pfizer Inc is involved in the pharmaceutical industry and distributes products through Pfizer Labs.*

Pfizer Logo - sutent 07

Pfizer Logo - sutent 07

"Distributed by Pfizer Labs, Division of Pfizer Inc, NY, NY 10017."*

PRINCIPAL DISPLAY PANEL - 12.5 mg Capsule Bottle Label - sutent 08

PRINCIPAL DISPLAY PANEL - 12.5 mg Capsule Bottle Label - sutent 08

Store at 20-25°C (68-77°F). Always dispense with medication guide. NDC 0069-0550-38. Pfizer's Sutent contains sunitinib malate in capsules. Made in Singapore, each bottle has 28 capsules and is for prescription use only.*

PRINCIPAL DISPLAY PANEL - 25 mg Capsule Bottle Label - sutent 09

PRINCIPAL DISPLAY PANEL - 25 mg Capsule Bottle Label - sutent 09

'Store at 20°C to 25°C (68°F to 77°F). ALWAYS DISPENSE WITH MEDICATON GUIDE. Sutent (sunitinib malate) e Capsules. NDC 0069-0770-38. 28 Capsules Rxonly. PRINTED ON LINE/ STAMPATO IN LINEA.'*

PRINCIPAL DISPLAY PANEL - 50 mg Capsule Bottle Label - sutent 10

PRINCIPAL DISPLAY PANEL - 50 mg Capsule Bottle Label - sutent 10

PRINCIPAL DISPLAY PANEL - 37.5 mg Capsule Bottle Label - sutent 11

PRINCIPAL DISPLAY PANEL - 37.5 mg Capsule Bottle Label - sutent 11

* The product label images have been analyzed using a combination of traditional computing and machine learning techniques. It should be noted that the descriptions provided may not be entirely accurate as they are experimental in nature. Use the information in this page at your own discretion and risk.